MoneyWorks4Me

Alkem Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Alkem Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1788.00
Dr. Reddys Labs. 1198.30
Cipla 1335.70
Lupin 2012.65
Zydus Lifesciences 1143.70
View more..